everolimus Oral Suspension

Brand(s)
Afinitor
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Novartis Pharmaceuticals Corporation (2015-09-18)
RxNORM
ORAL SUSPENSION\EVEROLIMUS
SPL Active
ORAL\TABLET, FOR SUSPENSION\EVEROLIMUS
SPL Moiety
ORAL\TABLET, FOR SUSPENSION\EVEROLIMUS

product(s) by strength(s)

everolimus 0.08 mg/ml oral suspension

product(s)(s)

#idbrandlabeleractive ingredient(s)routedose formspl
1000780626AfinitorNovartis Pharmaceuticals CorporationEVEROLIMUSORALTABLET, FOR SUSPENSION2150f73a-179b-4afc-b8ce-67c85cc72f04

everolimus 0.12 mg/ml oral suspension

product(s)(s)

#idbrandlabeleractive ingredient(s)routedose formspl
1000780627AfinitorNovartis Pharmaceuticals CorporationEVEROLIMUSORALTABLET, FOR SUSPENSION2150f73a-179b-4afc-b8ce-67c85cc72f04

everolimus 0.2 mg/ml oral suspension

product(s)(s)

#idbrandlabeleractive ingredient(s)routedose formspl
1000780628AfinitorNovartis Pharmaceuticals CorporationEVEROLIMUSORALTABLET, FOR SUSPENSION2150f73a-179b-4afc-b8ce-67c85cc72f04

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)in other drug docs
12150f73a-179b-4afc-b8ce-67c85cc72f04 (view SPL)These highlights do not include all the information needed to use AFINITOR safely and effectively. See full prescribing information for AFINITOR. AFINITOR (everolimus) tablets for oral administration AFINITOR DISPERZ (everolimus tablets for oral suspension) Initial U.S. Approval: 2009prescriptionHuman PrescriptionNovartis Pharmaceuticals Corporation2015-09-1834000780626, 000780627, 000780628, 000780566, 000780567, 000780594, 000780620everolimus Oral Tablet

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII